跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
卫力迦 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Efgartigimod Alfa Injection (Subcutaneous Injection)
Approved
生物制品
Efgartigimod Alfa Injection (Subcutaneous Injection)
ARGENX BV
🇨🇳 National Medical Products Administration
Approval Date
Jul 9, 2024
Approval ID
8beaIMrSpyV
Company
ARGENX BV
Type
生物制品
Approval Details
Approval Id
8beaIMrSpyV
Approval Number
国药准字SJ20240029
Generic Name
艾加莫德α注射液(皮下注射)
Generic Name En
Efgartigimod Alfa Injection (Subcutaneous Injection)
Trade Name
卫力迦
Drug Type
生物制品
Dosage Form
注射剂
Strength
1000mg（5.6ml）/瓶
Reg Date
2024-07-09
Expired Date
2029-07-08
Company Name
ARGENX BV
Production Company Name
PATHEON ITALIA SPA
Company Detail Path
/organization/argenx-bv
Production Company Detail Path
/organization/patheon-italia-spa
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jul 9, 2024
Approval ID
8beaIMrSpyV
Type
生物制品
Back to NMPA Approvals
